Literature DB >> 7836775

Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions.

J D Ohmen1, J M Hanifin, B J Nickoloff, T H Rea, R Wyzykowski, J Kim, D Jullien, T McHugh, A S Nassif, S C Chan.   

Abstract

The skin lesions of patients with atopic dermatitis provide a model to study immunoregulation in human allergy. To determine the local cytokine pattern of cells present (both endogenous and recruited) at the site of disease, we extracted RNA from skin biopsy specimens from patients with atopic dermatitis, allergic contract dermatitis, and positive tuberculin reactions and used PCR to assay for cytokine mRNA. cDNAs were normalized to the intensity of the CD3 delta PCR product as a marker of T cell mRNA. We found overexpression of IL-10 mRNA in atopic dermatitis lesions, in comparison with allergic contact dermatitis lesions and tuberculin reactions. In contrast, IL-4 mRNA was most strongly expressed in allergic contact dermatitis lesions and IFN-gamma mRNA was the predominant cytokine in tuberculin reactions. Using an anti-IL-10 mAb with immunoperoxidase, we localized IL-10 protein to large mononuclear cells in the dermal infiltrate of atopic lesions. After immunomagnetic sorting of mononuclear cell populations from PBMC of atopic dermatitis subjects, IL-10 mRNA as measured by PCR was found to be strongly expressed in CD14+ cells. Spontaneous release of IL-10 from PBMC-derived adherent cells was greater in atopic dermatitis donors than normal controls. We therefore renormalized skin biopsy cDNA according to the level of beta-actin PCR product, as a marker of total cellular mRNA, and found by PCR that IL-10 was nevertheless greatest in atopic dermatitis subjects. We conclude that the relative overexpression of IL-10 in atopic dermatitis greatest in atopic dermatitis subjects. We conclude that the relative overexpression of IL-10 in atopic dermatitis may contribute to the up-regulation of humoral responses and the down-regulation of Th1 responses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7836775

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26.

Authors:  N Katoh; S Hirano; M Suehiro; K Ikenaga; T Yamashita; N Sugawara; H Yasuno
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model.

Authors:  L Chen; O Martinez; L Overbergh; C Mathieu; B S Prabhakar; L S Chan
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

Review 3.  Cutaneous perspectives on adaptive immunity.

Authors:  Michael Girardi
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

4.  Mechanisms of anti-carcinogenesis by indole-3-carbinol. Studies of enzyme induction, electrophile-scavenging, and inhibition of aflatoxin B1 activation.

Authors:  A T Fong; H I Swanson; R H Dashwood; D E Williams; J D Hendricks; G S Bailey
Journal:  Biochem Pharmacol       Date:  1990-01-01       Impact factor: 5.858

5.  IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.

Authors:  K Asadullah; W Sterry; K Stephanek; D Jasulaitis; M Leupold; H Audring; H D Volk; W D Döcke
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

Review 6.  The spectrum of cutaneous patch-test reactions in patients with atopic dermatitis.

Authors:  J M Hanifin; P A Klas
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

Review 7.  Aeroallergen contact dermatitis.

Authors:  A Taïeb; G Ducombs
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

8.  Reduced production of both Th1 and Tc1 lymphocyte subsets in atopic dermatitis (AD).

Authors:  A Lonati; S Licenziati; A D Canaris; S Fiorentini; G Pasolini; M Marcelli; S Seidenari; A Caruso; G De Panfilis
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 9.  [Atopic patch test. Atopic eczema and allergy].

Authors:  U Darsow; J Ring
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

10.  Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.

Authors:  M Zöller; P Freyschmidt-Paul; M Vitacolonna; K J McElwee; S Hummel; R Hoffmann
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.